NEW YORK, June 11 (Reuters) - O Positiv Health is

exploring a sale that could value the women's health supplements

company at around $1 billion, according to three people familiar

with the matter.

The founder-owned business is working with investment bank

Jefferies on the sale effort, said the sources, who added that O

Positiv is projecting $275 million of revenue this year after

generating around $225 million in 2024.

The sources cautioned that no deal was guaranteed, and spoke

on condition of anonymity to discuss private information.

Jefferies declined to comment. O Positiv did not respond to

a comment request.

Siblings Bobby and Brianna Bitton launched O Positiv in

2018. The company makes vitamins and probiotics that address a

variety of health concerns, from PMS and menopause symptoms to

vaginal and gut health.

The products are sold on the company's website, as well as

through retailers including Walmart ( WMT ), Target ( TGT ) and

Amazon ( AMZN ).

Consumer health companies and private equity firms alike

have put more emphasis on investing in the women's health space

in recent years, which has created a significant pool of buyers

for brands founded by entrepreneurs.

Such deals include Pharmavite buying Bonafide in November

2023 and L Catterton, in partnership with actress Naomi Watts,

acquiring Stripes Beauty last year.